BioCentury
ARTICLE | Company News

Elan and Neurome in Alzheimer's deal

October 20, 2000 7:00 AM UTC

Neurome (La Jolla, Calif.) will use ELN's amyloid deposition mouse model of Alzheimer's to identify and exploit molecules and pathways for the treatment and diagnosis of the disease. Neurome will rece...